Benefits provider GroupHEALTH Benefit Solutions has entered into an exclusive partnership with licensed medical cannabis producer Zenabis.
Both companies have partnered for the “No Max Medical Cannabis Program,” which will be made available to GroupHEALTH clients this fall.
A release claims that this partnership is the first agreement of its kind in Canada, and it hopes to set a precedent for providing affordable medical cannabis to Canadians.
Under the partnership, GroupHEALTH’s advisor partners will work with employers to determine whether the “No Max Medical Cannabis Program” is the right solution for their business. Once viability has been confirmed, the medical cannabis program is then integrated into the client’s benefit plan design.
Afterwards, Zenabis’s medical cannabis experts will coordinate with plan members to confirm the correct cannabis treatment and dosage they need. Zenabis will also suggest appropriate solutions to health issues from their range of products, as well as delivering medication to plan members across Canada.
Pricing for the medical cannabis program is on a set-fee basis – this means clients will not be affected by market or claims volatility. Zenabis will also exclusively process prescriptions and purchases for plan members, ensuring that employees are receiving safe treatments from a reputable producer.
“Canadian employers are increasingly seeking a safe and sustainable way to integrate medical cannabis into benefit plans,” said GroupHEALTH CEO Matt Houghton in a statement. “GroupHEALTH’s No Maximum Medical Cannabis Program is an innovative approach that provides employees with superior coverage, while ensuring that employers’ costs are contained; both of which are GroupHEALTH hallmarks.”
“As a trusted and reliable supplier of medical cannabis, Zenabis looks forward to offering a full array of medicinal products at the highest quality. Quite frankly – this is a landmark agreement and it positions our company as a leading provider of medicinal cannabis,” added Zenabis CEO Kevin Cott.
